Repeated intravenous cardiosphere-derived cell therapy in late-stage Duchenne muscular dystrophy (HOPE-2): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

Allogeneic cardiosphere-derived cells (CAP-1002) in critically ill COVID-19 patients: compassionate-use case series

(2020) Siddharth Singh et al.   BASIC RESEARCH IN CARDIOLOGY

Intracoronary ALLogeneic heart STem cells to Achieve myocardial Regeneration (ALLSTAR): a randomized, placebo-controlled, double-blinded trial

(2020) Raj R Makkar et al.   EUROPEAN HEART JOURNAL

Cardiac and skeletal muscle effects in the randomized HOPE-Duchenne trial

(2019) Michael Taylor et al.   NEUROLOGY

Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology

(2019) Petar M. Seferović et al.   EUROPEAN JOURNAL OF HEART FAILURE

Performance of Upper Limb module for Duchenne muscular dystrophy

(2019) Anna G Mayhew et al.   DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY

Prevalence of Anti-Adeno-Associated Virus Immune Responses in International Cohorts of Healthy Donors

(2019) Anita Kruzik et al.   Molecular Therapy-Methods & Clinical Development

Prevalence and long-term monitoring of humoral immunity against adeno-associated virus in Duchenne Muscular Dystrophy patients

(2018) Christian Leborgne et al.   CELLULAR IMMUNOLOGY

Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study

(2018) Craig M McDonald et al.   LANCET

Upper limb function in Duchenne muscular dystrophy: 24 month longitudinal data

(2018) Marika Pane et al.   PLoS One

Exosome-Mediated Benefits of Cell Therapy in Mouse and Human Models of Duchenne Muscular Dystrophy

(2018) Mark A. Aminzadeh et al.   Stem Cell Reports

A mechanistic roadmap for the clinical application of cardiac cell therapies

(2018) Eduardo Marbán   Nature Biomedical Engineering

Longitudinal Pulmonary Function Testing Outcome Measures in Duchenne Muscular Dystrophy: Long-term Natural History with and without Glucocorticoids

(2018) Craig M. McDonald et al.   NEUROMUSCULAR DISORDERS

Cardiac Management of the Patient With Duchenne Muscular Dystrophy

(2018) Sujatha Buddhe et al.   PEDIATRICS

The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review

(2017) S. Ryder et al.   Orphanet Journal of Rare Diseases

Development of a patient-reported outcome measure for upper limb function in Duchenne muscular dystrophy: DMD Upper Limb PROM

(2016) K Klingels et al.   DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY

Macrophages mediate cardioprotective cellular postconditioning in acute myocardial infarction

(2015) Geoffrey de Couto et al.   JOURNAL OF CLINICAL INVESTIGATION

Fibroblasts Rendered Antifibrotic, Antiapoptotic, and Angiogenic by Priming With Cardiosphere-Derived Extracellular Membrane Vesicles

(2015) Eleni Tseliou et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Immune-mediated pathology in Duchenne muscular dystrophy

(2015) Amy S. Rosenberg et al.   Science Translational Medicine

The cooperative international neuromuscular research group duchenne natural history study-a longitudinal investigation in the era of glucocorticoid therapy: Design of protocol and the methods used

(2013) Craig M. McDonald et al.   MUSCLE & NERVE